Considering the intriguing dual role of TIMP1 in regulating pathways of cancer progression in a bi-phasic manner as described previously [2,5,6,7] and recent evidence that TIMPs can function as alarmins [10,11,12], we examined the effects on ILCs as a focus for our current study. Here, TIMP1 is linked to cancer.